Page last updated: 2024-11-05

2,4-thiazolidinedione and Liver Failure

2,4-thiazolidinedione has been researched along with Liver Failure in 2 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Liver Failure: Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)

Research Excerpts

ExcerptRelevanceReference
"Troglitazone (TGZ) is an orally active hypoglycemic agent which is used for the treatment of non-insulin-dependent diabetes mellitus."1.36Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity. ( Chan, EC; Chui, WK; Ho, HK; New, LS; Saha, S, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saha, S1
New, LS1
Ho, HK1
Chui, WK1
Chan, EC1
Isley, WL1
Oki, JC1

Reviews

1 review available for 2,4-thiazolidinedione and Liver Failure

ArticleYear
Hepatotoxicity of thiazolidinediones.
    Diabetes, obesity & metabolism, 2001, Volume: 3, Issue:6

    Topics: Humans; Hypoglycemic Agents; Liver; Liver Failure; Liver Transplantation; Thiazoles; Thiazolidinedio

2001

Other Studies

1 other study available for 2,4-thiazolidinedione and Liver Failure

ArticleYear
Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity.
    Toxicology letters, 2010, Feb-01, Volume: 192, Issue:2

    Topics: Cell Line; Cell Survival; Chromans; Drug Stability; Glutathione; Hepatocytes; Humans; Hypoglycemic A

2010